This impact paper identifies the contribution that various health care cost drivers, including COVID-19, have on projections for health care expenditures in Canada.
Health Care Cost Drivers in Canada: Pre-and Post-COVID-19
Health Care Cost Drivers in Canada: Pre-and Post-COVID-19
$0.00
- Projections conducted prior to COVID-19 suggest that health care expenditures would increase steadily over the next 10 years. Based on the level of new expenditures already incurred by governments, COVID-19 represents a significant new cost driver that will further impact health care spending, particularly over the short to medium terms.
- This impact paper examines three scenarios to determine the scope and magnitude of additional health care spending associated with the pandemic. The scenarios suggest the additional health costs will range from $20.1 billion to $26.9 billion in 2020–21 and between $15.7 billion and $21.9 billion in 2021–22. By 2030–31, the pandemic will result in an additional $80 billion to $161 billion in health care expenditures and contribute to overall health care spending increasing at an average annual rate of between 5.5 and 5.7 per cent, depending on the scenario.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
